Patents by Inventor Maria Åkerman

Maria Åkerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220098247
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: April 26, 2021
    Publication date: March 31, 2022
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Helena COWLEY, Aaron COWLEY, Maria ÅKERMAN
  • Publication number: 20210386793
    Abstract: The present invention relates to the treatment or prevention of oxalate-related disorders, more particularly to the use of a pharmaceutical composition comprising Oxalobacter formigenes in the treatment or prevention of systemic oxalosis with cardiac involvement.
    Type: Application
    Filed: October 4, 2019
    Publication date: December 16, 2021
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Bastian DEHMEL, Maria ÅKERMAN
  • Publication number: 20210052670
    Abstract: The present disclosure is related to pharmaceutical compositions and methods for treating and/or preventing oxalate-related disorders. More particularly, the present disclosure pertains to compositions comprising an oxalate-degrading bacteria Oxalobacter formigenes particularly suitable for the treatment and/or prevention of late stage hyperoxaluria characterized by high plasma-oxalate levels and a progressing decrease in kidney function.
    Type: Application
    Filed: September 2, 2020
    Publication date: February 25, 2021
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Maria ÅKERMAN, Anna SJÖGREN, Orla MCCALLION
  • Publication number: 20190125807
    Abstract: The present disclosure is related to pharmaceutical compositions and methods for treating and/or preventing oxalate-related disorders. More particularly, the present disclosure pertains to compositions comprising an oxalate-degrading bacteria Oxalobacter formigenes particularly suitable for the treatment and/or prevention of late stage hyperoxaluria characterized by high plasma-oxalate levels and a progressing decrease in kidney function.
    Type: Application
    Filed: June 13, 2017
    Publication date: May 2, 2019
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Maria ÅKERMAN, Anna SJÖGREN, Orla MCCALLION
  • Publication number: 20190085035
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: September 27, 2018
    Publication date: March 21, 2019
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Åkerman